Herpes Simplex Virus Type 1-Derived Recombinant and Amplicon Vectors

Methods in Molecular Biology

Volumn 737, Issue , 2011, Pages 303-343

  Fraefel, Cornel ^c   Marconi, Peggy ^c   Epstein, Alberto L ^a,b  

^a UNIVERSITÉ LYON 1   (France)

^b CNRS   (France)

^c NONE

Author keywords

Amplicon vectors; HSV 1; Recombinant vectors

Indexed keywords

RECOMBINANT DNA;

ANIMAL; ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; CELL LINE; CULTURE TECHNIQUE; ELECTROPORATION; ESCHERICHIA COLI; GENE VECTOR; GENETIC RECOMBINATION; GENETIC TRANSFECTION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HELPER VIRUS; HERPES SIMPLEX VIRUS 1; HUMAN; ISOLATION AND PURIFICATION; METHODOLOGY; MOLECULAR CLONING; PLASMID; TITRIMETRY; VIRION; VIROLOGY;

ANIMALS; CELL CULTURE TECHNIQUES; CELL LINE; CHROMOSOMES, ARTIFICIAL, BACTERIAL; CLONING, MOLECULAR; DNA, RECOMBINANT; ELECTROPORATION; ESCHERICHIA COLI; GENETIC VECTORS; HELPER VIRUSES; HERPESVIRUS 1, HUMAN; HUMANS; PLASMIDS; RECOMBINATION, GENETIC; TITRIMETRY; TRANSFECTION; VIRION;

EID: 80052310355     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-61779-095-9_13     Document Type: Chapter

References (36)

1. Roizman, B., and Knipe, D.M. Herpes simplex viruses and their replication. In: Knipe DM, Howley PM (eds). Fields Virology. Lippincot, Williams and Wilkins: Philadelphia, PA, 2001, pp. 2399–2460.
2. Marozin, S., Prank, U., and Sodeik, B. (2004) Herpes simplex virus type 1 infection of polarized epithelial cells requires microtubules and access to receptors present at cell-cell contact sites. J. Gen. Virol. 85, 775–786.
3. Honess, R.W., and Roizman, B. (1975) Regulation of herpesvirus macromolecular synthesis: sequential transition of polypeptide synthesis requires functional viral polypeptides. Proc. Natl. Acad. Sci. USA. 72, 1276–1280.
4. Batterson, W., and Roizman, B. (1983) Characterization of the herpes simplex virionassociated factor responsible for the induction of alpha genes. J. Virol. 46, 371–377.
5. Skepper, J.N., Whiteley, A., Browne, H., and Minson, A. (2001) Herpes simplex virus nucleocapsids mature to progeny virions by an envelopment > deenvelopment > reenvelopment pathway. J. Virol. 75, 5697–5702.
6. Deshmane, S.L., and Fraser, N.W. (1989) During latency, herpes simplex virus type 1 DNA is associated with nucleosomes in a chromatin structure. J. Virol. 63, 943–947.
7. Farrell, M.J., Dobson, A.T., Feldman, L.T. (1991) Herpes simplex virus latency-associated transcript is a stable intron. Proc. Natl. Acad. Sci. U S A. 88, 790–794.
8. Umbach, J.L., Kramer, M.F., Jurak, I., Karnowski, H.W., Coen, D.M., and Cullen, B.R. (2008) MicroRNAs expressed by herpes simplex virus 1 during latent infection regulate viral mRNAs. Nature 454, 780–783.
9. Preston, C.M. (2000) Repression of viral transcription during herpes simplex virus latency. J. Gen. Virol. 8, 1–19.
10. Todo, T. (2008) Oncolytic virus therapy using genetically engineered herpes simplex viruses. Front. Biosci. 13, 2060–2064.
11. Burton, E.A., Fink, D.J., and Glorioso, J.C. (2005) Replication-defective genomic HSV gene therapy vectors: design, production and CNS applications. Curr. Opin. Mol. Ther. 7, 326–336.
12. Oehmig, A., Fraefel, C., and Breakefield, X.O. (2004) Update on herpesvirus amplicon vectors. Mol. Ther. 10, 630–643.
13. Cuchet, D., Potel, C., Thomas, J. and Epstein, A.L. (2007) HSV-1 amplicon vectors: a promising and versatile tool for gene delivery. Expert Opin. Biol. Ther. 7, 975–995.
14. Manservigi, R., Argnani, R., Marconi, P. and Epstein, A.L. (2007). Herpesvirus-based vectors for gene transfer, gene therapy, and the development of novel vaccines. In Virus Expression Vectors, pp205–246. Ed. Kathleen L. Hefferon. Transworld Research Network.
15. Krisky, D.M., Marconi, P.C., Oligino, T.J., Rouse, R.J., Fink, D.J., Cohen, J.B., Watkins, S.C., and Glorioso, J.C. (1998) Development of herpes simplex virus replication-defective multigene vectors for combination gene therapy applications. Gene Ther. 5, 1517–1530.
16. Wu, N., Watkins, S.C., Schaffer, P.A., and DeLuca, N.A. (1996) Prolonged gene expression and cell survival after infection by a herpes simplex virus mutant defective in the immediate-early genes encoding ICP4, ICP27, and ICP22. J. Virol. 70, 6358–6369.
17. Samaniego, L.A., Neiderhiser, L., and DeLuca N.A. (1998) Persistence and expression of the herpes simplex virus genome in the absence of immediate-early proteins. J. Virol. 72, 3307–3320.
18. Berto, E., Bozac, A., and Marconi, P. (2005) Development and application of replicationincompetent HSV-1-based vectors. Gene Ther. 12 Suppl 1:S98–S102.
19. Krisky, D.M., Wolfe, D., Goins, W.F., Marconi, P.C., Ramakrishnan, R., Mata, M., Rouse,
20. R.J., Fink, D.J., and Glorioso, J.C. (1998) Deletion of multiple immediate-early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neurons. Gene Ther. 5,1593–1603.
21. Advani, S.J., Weischelbaum, R.R., Whitley, R.J., and Roizman, B. (2002) Friendly fire: redirecting herpes simplex virus-1 for therapeutic applications. Clin. Microbiol. Infect. 8, 551–563.
22. Argnani, R., Lufino, M., Manservigi, M., and Manservigi, R. (2005) Replication-competent herpes simplex vectors: design and applications. Gene Ther. 12 Suppl 1:S170–177.
23. Nawa, A., Luo, C., Zhang, L., Ushjima, Y., Ishida, D., Kamakura, M., Fujimoto, Y., Goshima, F., Kikkawa, F., and Nishiyama, Y. (2008) Non-engineered, naturally oncolytic herpes simplex virus HSV1 HF-10: applications for cancer gene therapy. Curr. Gene Ther. 8, 208–221.
24. Gage, P.J., Sauer, B., Levine, M., and Glorioso, J.C. (1992) A cell-free recombination system for site-specific integration of multigenic shuttle plasmids into the herpes simplex virus type 1 genome. J. Virol. 66, 5509–5515.
25. Rinaldi, A., Marshall, K.R., Preston, C.M. (1999) A non-cytotoxic herpes simplex virus vector which expresses Cre recombinase directs efficient site specific recombination. Virus Res. 65, 11–20.
26. Stricklett, P.K., Nelson, R.D., and Kohan, D.E. (1998) Site-specific recombination using an epitope tagged bacteriophage P1 Cre recombinase. Gene 215, 415–423.
27. Krisky, D.M., Marconi, P.C., Oligino, T., Rouse, R.J., Fink, D.J., and Glorioso, J.C. (1997) Rapid method for construction of recombinant HSV gene transfer vectors. Gene Ther. 4, 1120–1125.
28. Saeki, Y., Ichikawa, T., Saeki, A., Chiocca, E.A., Tobler, K., Ackermann, M., Breakefield, X.O., and Fraefel, C. (1998) Herpes simplex virus type 1 DNA amplified as bacterial artificial chromosome in Escherichia coli: rescue of replication-competent virus progeny and packaging of amplicon vectors. Human Gene Ther. 9, 2787–2794.
29. Tanaka, M., Kagawa, H., Yamanashi, Y., Sata, T., and Kawaguchi, Y. (2003) Construction of an excisable bacterial artificial chromosome containing a full-length infectious clone of herpes simplex virus type 1: viruses reconstituted from the clone exhibit wild-type properties in vitro and in vivo. J. Virol. 77, 1382–91.
30. Fraefel, C., Song, S., Lim, F., Lang, P., Yu, L., Wang, Y., Wild, P., and Geller, A.I. (1996). Helper virus-free transfer of herpes simplex virus type 1 plasmid vectors into neural cells. J. Virol. 70, 7190–7197.
31. Saeki, Y., Fraefel, C., Ichikawa, T., Breakefield, X.O., Chiocca, E.A. (2001) Improved helper virus-free packaging system for HSV amplicon vectors using an ICP27-deleted, oversized HSV-1 DNA in a bacterial artificial chromosome. Mol. Ther. 3, 591–601.
32. Zaupa, C., Revol-Guyot, V. and Epstein, A.L. (2003) Improved packaging system for generation of high levels non-cytotoxic HSV-1 amplicon vectors using Cre-loxP site-specific recombination to delete the packaging signals of defective helper genomes. Hum. Gene Ther. 14, 1049–1063.
33. Warming, S., Costantino, N., Court, D.L., Jenkins, N.A., and Copeland, N.G. (2005) Simple and highly efficient BAC recombineer ing using galK selection. Nucleic Acids Res. 33:e36.
34. Smith, I.L., Hardwicke, M.A., and Sandri Goldin, R.M. (1992) Evidence that the herpes simplex virus immediate early protein ICP27 acts post-transcriptionally during infection to regulate gene expression. Virology 186, 74–86.
35. Kashima, T., Vinters, H.V., and Campagnoni, A.T. (1995) Unexpected expression of intermediate filament protein genes in human oligodendroglioma cell lines. J. Neuropathol. Exp. Neurol. 54, 23–31.
36. McGeoch, D.J., Dalrymple, M.A., Davison, A.J., Dolan, A., Frame, M.C., McNab, D., Perry, L.J., Scott, J.E., and Taylor, P. (1988) The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1. J. Gen. Virol. 69, 1531–15374.